Press release
Valvular Heart Diseases Treatment Market 2018 Size, Growth Analysis Report, Forecast to 2023
Request a Free Sample of our Valvular Heart Diseases Treatment Market: https://www.omrglobal.com/request-sample/valvular-heart-diseases-treatment-market
The heart treatments and the certification to perform it is very expensive and time-consuming process due to the stringent regulation of the government and medical authority. Additionally, the lack of expertise and medical practitioners for heart surgery or therapy can hinder the growth of the market. Whereas, the future of surgery for acquired heart disease is quite promising due to the rapid development of invasive cardiology and the adoption of minimally invasive techniques for heart surgery. And the continuous R&D in the field of valve replacement and adult cardiac surgery such as treatment for valvular heart diseases is evolving at a rapid pace. Improvement in healthcare infrastructure will create the huge opportunity for such treatment in market.
Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America is growing with significant growth and is dominating the overall global valvular heart diseases treatment market due to increased heart failure cases and the excessive consumption of alcohol. Europe is the second largest market due to the high adoption of minimally-invasive technology and technological advancement in the healthcare sector. The improvement in healthcare infrastructure and rising awareness of heart diseases and treatment is the driving factor for the growth of the valvular heart diseases market in the Asia-Pacific.
A full Report of Valvular Heart Diseases Treatment Market is Available at: https://www.omrglobal.com/industry-reports/valvular-heart-diseases-treatment-market
• Valvular Heart Diseases Treatment MARKET SEGMENTATION
By Diseases
•
Aortic Valve Replacement
Heart Valve Disease
Mitral Valve Stenosis
Others (Tricuspid Valve Disorders)
•
By Diagnosis
Cardiac Catheterization
Electrocardiogram (ECG)
Chest X-Ray
Stress Testing
Others
By Treatment
• Medication
Surgery
Valve Repair
Valve Replacement
By End-Users
•
Hospital & Clinics
Ambulatory Surgical Centers
Research Institutes
•
COMPETITIVE LANDSCAPE
•
Key Strategy Analysis
Key Company Analysis
REGIONAL ANALYSIS
•
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
RoE
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Rest of the World (RoW)
•
COMPANY PROFILES
•
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp.
Braile Biomédica
C. R. Bard, Inc.
Cardiac Dimensions Pty. Ltd.
CardiaMed
Cardiosolutions, Inc.
Cook Group Inc.
CryoLife, Inc.
Edwards Lifesciences Corp.
HLT, Inc.
InterValve Medical Inc.
JenaValve Technology, Inc.
Labcor Laboratórios Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
LivaNova PLC
Medtronic, PLC
Micro Interventional Devices, Inc.
NeoChord, Inc.
Neovasc Inc.
ON-X Life Technologies Inc.
Osypka Medical GmbH
Siemens Healthcare Medical Solutions Ltd.
Terumo Corp.
Toray Industries, Inc.
TTK Healthcare Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/valvular-heart-diseases-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Valvular Heart Diseases Treatment Market 2018 Size, Growth Analysis Report, Forecast to 2023 here
News-ID: 2224447 • Views: …
More Releases from Orion Market Research
Sleep Apnea Implants Market Is Expected To Exhibit Significant Growth Over 2031
The global sleep apnea implants market is anticipated to grow at a CAGR of 10.6% during the forecast period. The rising geriatric population creating demand for global sleep apnea implants market during the forecast period. As per the study conducted by European Respiratory Society, the obstructive sleep apnea is a common disorder in older people; 13%-32% of people over 65 yrs old are highly susceptible to sleep apnea. According to…
Radiofrequency ablation (RF) Devices Market Will Exhibit an Impressive Expansion …
The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period. The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches,…
Nasal Drug Delivery Market Is Expected To Exhibit Significant Growth Over 2031
The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
A full report of Nasal…
Myocardial Infarction Market Is Expected To Exhibit Significant Growth Over 2031
The global myocardial infarction market is anticipated to grow at a CAGR of around 6.6% during the forecast period. Factors contributing to the growth of the myocardial infarction market include rising incidence rate of CVDs (cardiovascular diseases) and intake of high-level sugary food, which significantly boost the prevalence of CADs (coronary artery diseases). According to the American Heart Association estimates, CVD is the leading global cause of death and accounted…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
